GlassScriptPhysician profile
Sudhanshu Prasad
NPI 1982626453
$7,213.21
in general payments reported to CMS, 2019-2025
48 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,187 · 2020: $672 · 2021: $1,649 · 2022: $1,251 · 2023: $1,574 · 2024: $500 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,454.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,035.63 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $871.80 | 2019-2024 | Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $638.97 | 2019-2024 | Jardiance |
| Amgen INC. | $611.44 | 2019-2025 | Repatha, Otezla, Otezla |
| Sanofi-Aventis U.S. LLC | $488.27 | 2019-2023 | |
| Lilly USA, LLC | $468.64 | 2019-2024 | Mounjaro, Trulicity |
| Janssen Pharmaceuticals, INC | $421.29 | 2019-2024 | Xarelto |
| Pfizer INC. | $302.40 | 2019-2025 | |
| Intuity Medical INC | $292.21 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Mannkind Corporation | $232.24 | 2021-2025 | Afrezza |
| Dexcom, INC. | $198.14 | 2021-2023 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $151.28 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $139.46 | 2021-2023 | Unithroid |
| Amarin Pharma, INC. | $132.73 | 2019-2021 | |
| Boston Scientific Corporation | $124.97 | 2023 | Watchman Access System |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sudhanshu Prasad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.